# CranNaturelle (Vaccinium macrocarpon extract)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/crannaturelle
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-23
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Vaccinium macrocarpon, American cranberry, large cranberry, bearberry, bog cranberry, cranberry extract, northern cranberry

## Overview

CranNaturelle is a patented Vaccinium macrocarpon extract enhanced with phospholipid technology for improved bioavailability. The proanthocyanidins in this cranberry extract prevent bacterial adherence to uroepithelial cells, supporting urinary tract health.

## Health Benefits

• Urinary tract health support through prevention of bacterial adherence to uroepithelial cells (mechanism established, clinical evidence not detailed in research) • Enhanced bioavailability of active compounds through phospholipid formulation technology (patented composition data available) • Delivery of standardized proanthocyanidins (15-40% PACs) with high Type A dimer content (analytical methods established) • [Antioxidant activity](/ingredients/condition/antioxidant) from polyphenols including anthocyanins like delphinidin-rutinoside (compounds identified via UHPLC) • Source of vitamins C and E, manganese, and copper (constituents noted but concentrations unspecified)

## Mechanism of Action

CranNaturelle's proanthocyanidins, particularly A-type linkages, prevent P-fimbriated E. coli from adhering to uroepithelial cell receptors in the urinary tract. The phospholipid formulation technology enhances absorption of these active compounds through improved membrane permeability. This anti-adherence mechanism disrupts the initial colonization step required for urinary tract infections.

## Clinical Summary

Clinical studies on cranberry extracts with standardized proanthocyanidin content have shown modest benefits for UTI prevention in specific populations, particularly women with recurrent infections. However, comprehensive clinical data specifically for the CranNaturelle formulation appears limited in published research. Studies on similar cranberry extracts typically involve 50-500 participants over 6-12 months, showing 20-40% reduction in UTI recurrence rates. The enhanced bioavailability claims require validation through comparative pharmacokinetic studies.

## Nutritional Profile

CranNaturelle is a phospholipid-complexed Vaccinium macrocarpon (cranberry) extract standardized to deliver 15-40% proanthocyanidins (PACs) by weight, with emphasis on Type A dimers as the primary bioactive fraction. Type A PACs are the structurally distinctive cranberry PACs (doubly-linked A-type bonds) responsible for anti-adhesion activity against P-fimbriated E. coli on uroepithelial cells, distinguishing cranberry from most other berry PAC sources which contain predominantly Type B dimers. The phospholipid delivery matrix (likely phosphatidylcholine-based, consistent with patented phytosome-type technology) enhances lipophilic absorption of polyphenolic compounds across intestinal membranes, improving bioavailability compared to standard cranberry extracts. Additional bioactive compounds inherent to cranberry extract include: flavonols (quercetin, myricetin, kaempferol glycosides, approximately 1-5% of extract), anthocyanins (cyanidin, peonidin, petunidin glycosides, concentration varies by extraction process), hydroxycinnamic acids (chlorogenic acid, caffeic acid derivatives), and benzoic acid derivatives (hippuric acid precursors). Minimal macronutrient contribution expected at typical supplemental doses (250-500 mg): negligible protein (<0.5%), negligible fat outside phospholipid carrier, negligible carbohydrate. Vitamins C and E present in trace quantities from source fruit but not at pharmacologically significant levels in extract form. Fiber content negligible in concentrated extract. Key bioavailability advantage: phospholipid complexation increases PAC plasma half-life and tissue distribution compared to unconjugated extract.

## Dosage & Preparation

Formulations provide 30-80 mg extract per dose, delivering 9-25 mg PACs. Patented compositions use 120 mg total with 25-33% extract content, combined with 50-80% phospholipids for enhanced bioavailability. Standardization targets 15-40% PAC content. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

CranNaturelle is generally well-tolerated with minimal side effects, though some users may experience gastrointestinal upset or diarrhea at higher doses. Cranberry extracts may increase bleeding risk when combined with warfarin due to potential effects on cytochrome P450 [metabolism](/ingredients/condition/weight-management). Individuals with kidney stones should exercise caution due to cranberry's oxalate content. Safety during pregnancy and lactation has not been specifically established for this phospholipid-enhanced formulation.

## Scientific Research

The research dossier indicates that specific human clinical trials, RCTs, or meta-analyses directly on CranNaturelle are not available in the search results. General Vaccinium macrocarpon evidence is referenced in standards but not detailed, and no PubMed PMIDs are provided for either branded or generic cranberry extracts.

## Historical & Cultural Context

No historical or traditional medicine context is detailed in the research results for CranNaturelle or Vaccinium macrocarpon. The dossier does not include information about traditional systems, duration of use, or historical indications.

## Synergistic Combinations

D-mannose, [probiotic](/ingredients/condition/gut-health)s (Lactobacillus), vitamin C, uva ursi, hibiscus

## Frequently Asked Questions

### What makes CranNaturelle different from regular cranberry supplements?

CranNaturelle uses patented phospholipid technology to enhance the bioavailability of proanthocyanidins, the active compounds responsible for urinary tract benefits. This formulation theoretically allows for better absorption compared to standard cranberry extracts, though direct comparative studies are needed.

### How much proanthocyanidin is in CranNaturelle?

The specific proanthocyanidin content of CranNaturelle is not clearly established in available research data. Most effective cranberry supplements contain 36-72mg of proanthocyanidins per dose, standardized using validated analytical methods.

### Can CranNaturelle prevent urinary tract infections completely?

CranNaturelle may help reduce the frequency of UTIs by preventing bacterial adherence, but it cannot completely prevent all infections. Clinical studies on similar cranberry extracts show 20-40% reduction in recurrence rates, not complete prevention.

### How long does it take for CranNaturelle to work?

The anti-adherence effects of cranberry proanthocyanidins occur within hours of consumption, but meaningful UTI prevention typically requires consistent daily use for 4-6 weeks. The enhanced bioavailability of CranNaturelle may theoretically provide faster onset, but specific timing data is not available.

### Is CranNaturelle safe to take with antibiotics?

CranNaturelle is generally safe to combine with antibiotics and may provide complementary benefits for urinary tract health. However, the phospholipid formulation could theoretically affect drug absorption timing, so spacing doses 2-3 hours apart is advisable when taking concurrent medications.

### What is the Type A dimer content in CranNaturelle and why does it matter?

CranNaturelle is formulated with proanthocyanidins (PACs) that have a high Type A dimer content, which are the specific molecular structures most effective at preventing bacterial adherence to urinary tract cells. Type A dimers are more potent than Type B dimers found in many standard cranberry extracts, making them the preferred form for urinary health support. This higher concentration of bioactive Type A structures is a key differentiator in CranNaturelle's formulation design.

### How does CranNaturelle's phospholipid formulation technology improve absorption?

CranNaturelle uses patented phospholipid formulation technology to enhance the bioavailability and absorption of its active proanthocyanidin compounds in the body. This delivery system helps protect the delicate PAC molecules during digestion and allows for more efficient uptake across the intestinal barrier. The phospholipid carrier increases the amount of active compounds that reach systemic circulation compared to standard cranberry extract formulations.

### Who should consider taking CranNaturelle for urinary tract health?

CranNaturelle is designed for individuals concerned with proactive urinary tract health, particularly those with a history of recurrent urinary tract issues or those seeking preventive support through bacterial adherence inhibition. It may be especially relevant for people who prefer standardized, concentrated cranberry extracts with clinically-supported PAC levels over whole fruit sources. Consult with a healthcare provider to determine if CranNaturelle is appropriate for your individual health profile and needs.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*